ClinicalTrials.Veeva

Menu

Evaluation of Carbohydrates

Abbott logo

Abbott

Status

Completed

Conditions

Glycemic Index

Treatments

Other: CHO Experimental 3 Low Sugar
Other: CHO Experimental 2 Digestion Resistant
Other: CHO Control 1 and 2 Glucose
Other: CHO Experimental 4 Maltodextrin
Other: CHO Experimental 1 Slowly Digested

Study type

Interventional

Funder types

Industry

Identifiers

NCT03242122
BL37 Part 1

Details and patient eligibility

About

The study is open-label with a randomized, cross-over design using standard Gl methodology.

Enrollment

10 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects are males or non-pregnant females in good health.
  • Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.

Exclusion criteria

  • Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes or a heart condition.
  • Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

10 participants in 6 patient groups

CHO Control 1 Glucose
Active Comparator group
Description:
25 g glucose
Treatment:
Other: CHO Control 1 and 2 Glucose
CHO Experimental 1 Slowly Digested
Experimental group
Description:
25 g slowly-digested carbohydrate blend
Treatment:
Other: CHO Experimental 1 Slowly Digested
CHO Experimental 2 Digestion Resistant
Experimental group
Description:
25 g digestion-resistant carbohydrate blend
Treatment:
Other: CHO Experimental 2 Digestion Resistant
CHO Experimental 3 Low Sugar
Experimental group
Description:
25 g low sugar carbohydrate blend
Treatment:
Other: CHO Experimental 3 Low Sugar
CHO Experimental 4 Maltodextrin
Experimental group
Description:
25 g maltodextrin
Treatment:
Other: CHO Experimental 4 Maltodextrin
CHO Control 2 Glucose
Active Comparator group
Description:
25 g glucose
Treatment:
Other: CHO Control 1 and 2 Glucose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems